Acer2 - alkaline ceramidase 2 Gene
Also Known as Asah3l
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 313339
Summary
Predicted to enable dihydroceramidase activity. Predicted to be involved in several processes, including negative regulation of cell adhesion; regulation of cellular protein metabolic process; and sphingolipid metabolic process. Predicted to be located in Golgi apparatus. Predicted to be integral component of Golgi membrane. Orthologous to human ACER2 (alkaline Ceramidase 2). [provided by Alliance of Genome Resources, Apr 2022]
Acer2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001107943.2 | NP_001101413.1 | alkaline ceramidase 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
alkaline ceramidase 2 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13771 | Ursodeoxycholic acid | 99.94% | Unkown | |
| HY-B0260 | Methylprednisolone | 99.78% | Yes | |
| HY-12404 | Diminazene aceturate | 99.39% | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99346 | Regdanvimab | Inhibitor | 95.00% | Unkown |
| HY-P9801 | Anti-Spike-RBD mAb | / | Unkown |
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-19414 | MLN-4760 | Inhibitor | 99.93% | Phase 2 |
| HY-19088 | Oberadilol | Ligand | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(69)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14393 | Emodin | Inhibitor | 99.25% | Yes |
| HY-110066 | (Z)-Guggulsterone | 99.41% | Unkown | |
| HY-138113 | Pyrrothiogatain | Inhibitor | 98.61% | Unkown |
| HY-N0217 | Benzoylaconine | 99.92% | Unkown | |
| HY-N0639 | Punicalin | 99.88% | Unkown | |
| HY-15275 | BMS-265246 | Inhibitor | 99.59% | Unkown |
| HY-120852 | JG26 | 98.14% | Unkown | |
| HY-N2116 | Ginkgolic acid C17:1 | 99.80% | Unkown | |
| HY-113478S | Ursodeoxycholic acid-d4 | 99.52% | Unkown | |
| HY-B0260R | Methylprednisolone (Standard) | 98.90% | Unkown | |
| HY-P2536 | Mca-Ala-Pro-Lys(Dnp)-OH | 99.95% | Unkown | |
| HY-100450 | BML-111 | Inhibitor | 98.87% | Unkown |
| HY-P2222 | DX600 | Inhibitor | 99.71% | Unkown |
| HY-14393R | Emodin (Standard) | Inhibitor | 98.84% | Unkown |
| HY-163943 | UNI418 | Inhibitor | 99.61% | Unkown |
| HY-138067 | SSAA09E2 | Inhibitor | 98.37% | Unkown |
| HY-P2616A | Mca-YVADAP-Lys(Dnp)-OH TFA | Chemical | 98.29% | Unkown |
| HY-19414A | (R)-MLN-4760 | Inhibitor | 99.51% | Unkown |
| HY-126419 | Kobophenol A | Inhibitor | 99.90% | Unkown |
| HY-B0260S4 | Methylprednisolone-d2 | 99.11% | Unkown | |
| HY-D1270 | Direct Violet 1 | Inhibitor | / | Unkown |
| HY-P2222A | DX600 TFA | Inhibitor | 99.20% | Unkown |
| HY-157154 | MAT-POS-e194df51-1 | Inhibitor | 98.45% | Unkown |
| HY-122445 | Resorcinolnaphthalein | Activator | 99.87% | Unkown |
| HY-179630 | MS102 | Inhibitor | / | Unkown |
| HY-B0260S | Methylprednisolone-d3 | / | Unkown | |
| HY-B0260S3 | Methylprednisolone-d7 | 99.73% | Unkown | |
| HY-P3141 | STIEEQAKTFLDKFNHEAEDLFYQSSLASWN | 95.28% | Unkown | |
| HY-P3142 | NMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQ | 96.51% | Unkown | |
| HY-P5407A | HD5 TFA | Inhibitor | 95.30% | Unkown |
| HY-RS00152 | ACE2 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-W342283 | Diminazene | / | Unkown | |
| HY-B0260S6 | Methylprednisolone-d3-1 | / | Unkown | |
| HY-RS00001 | ACE2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-14393S | Emodin-d4 | Inhibitor | / | Unkown |
| HY-121068 | Bisoxatin | Inhibitor | / | Unkown |
| HY-121421 | Diniprofylline | Inhibitor | / | Unkown |
| HY-149373 | Garcinone B | Inhibitor | / | Unkown |
| HY-149767 | CMX990 | Inhibitor | 96.63% | Unkown |
| HY-156441 | SARS-CoV-2-IN-65 | Inhibitor | / | Unkown |
| HY-156862 | (+)-Chloroquine | Activator | / | Unkown |
| HY-157966 | SARS-CoV-2 3CLpro-IN-23 | Inhibitor | / | Unkown |
| HY-158073 | ML2006a4 | Inhibitor | / | Unkown |
| HY-161261 | SARS-CoV-2-IN-81 | Inhibitor | / | Unkown |
| HY-168267 | XH161-180 | Inhibitor | / | Unkown |
| HY-169405 | AAK1/HDACs-IN-1 | Inhibitor | / | Unkown |
| HY-169977 | CKP-25 | Inhibitor | / | Unkown |
| HY-170767 | SARS-CoV-2-IN-109 | Inhibitor | / | Unkown |
| HY-174350 | CK2-IN-15 | Inhibitor | / | Unkown |
| HY-174373 | SARS-CoV-2-IN-113 | Inhibitor | / | Unkown |
| HY-178160 | SARS-CoV-2 PLpro-IN-2 | Inhibitor | / | Unkown |
| HY-179634 | ASF-006 sodium | Inhibitor | / | Unkown |
| HY-181066 | ACE2-SP PPI-IN-1 | Inhibitor | / | Unkown |
| HY-B0260S2 | Methylprednisolone-d4 | / | Unkown | |
| HY-P11464 | SARS-CoV-2 Spike receptor binding domain, RBD (371-394) | / | Unkown | |
| HY-P2616 | Mca-YVADAP-Lys(Dnp)-OH | Chemical | / | Unkown |
| HY-P3258 | SP-10 | / | Unkown | |
| HY-P4546 | Abz-Ser-Pro-3-nitro-Tyr | / | Unkown | |
| HY-P5827 | SBP1 peptide | / | Unkown | |
| HY-RS00154 | ACER2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-161070 | Antiviral agent 46 | Inhibitor | / | Unkown |
| HY-162550 | Jobosic acid | Inhibitor | / | Unkown |
| HY-162598 | CET-1 | Inhibitor | / | Unkown |
| HY-175325 | SARS-CoV-2-IN-116 | Inhibitor | / | Unkown |
| HY-175475 | MolPort-010-778-422 | Inhibitor | / | Unkown |
| HY-175697 | Glycosyltransferase-IN-2 | Inhibitor | / | Unkown |
| HY-180129 | SARS-CoV-2-IN-120 | Inhibitor | / | Unkown |
| HY-P5407 | HD5 | Inhibitor | / | Unkown |
| HY-RS16513 | Ace2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990180 | Anti-Mouse NKG2A/C/E Antibody (20D5) | Inhibitor | 95.00% | Unkown |
| HY-P990731 | Canvircept | / | Unkown | |
| HY-P990814 | Anti-SARS-CoV-2 S protein Antibody (RBD epitope B, SARS2-34) | Inhibitor | / | Unkown |
| HY-P990815 | Anti-SARS-CoV-2 S protein Antibody (RBD epitope A, SARS2-01) | Inhibitor | / | Unkown |
| HY-P991491 | VIR-7229 | Inhibitor | / | Unkown |